Clinical Trials in Salt Lake City

Showing 9021-9040 of 12,670 trials

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

NCT02537470

This is a dose-ranging study to evaluate the efficacy, safety and tolerability of a range of doses of a biphasic formulation of remogliflozin etabonate compared to placebo, administered over 12 weeks in subjects with type 2 diabetes mellitus.

Type 2 Diabetes MellitusDiabetes Mellitus, Type 2

BHV Pharma191 participantsStarted Jul 2015

Tucson, Arizona, United States • Long Beach, California, United States • Long Beach, California, United States +16 more locations

COMPLETEDNA11 miles

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

NCT02649478

A Randomized, Parallel-Group, Placebo-Controlled, Clinical Endpoint Bioequivalence Study of Generic Fluticasone Propionate 100 µg and Salmeterol Xinafoate 50 µg Inhalation Powder Compared with Advair Diskus® 100/50 in Subjects with Asthma

Asthma

Roxane Laboratories1,430 participantsStarted Aug 2014

Glendale, Arizona, United States • Phoenix, Arizona, United States • Surprise, Arizona, United States +97 more locations

Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 Diabetes

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Find Trials by Condition in Salt Lake City

BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis

Effectiveness of Aurix Therapy in Pressure Ulcers

An Observational Cohort Study of the Safety and Efficacy of Fibrinogen Concentrate, Human (FCH) in Subjects With Congenital Fibrinogen Deficiency

Asthma Exacerbation Study

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Phase II Study of the Safety and Efficacy of the Relay Thoracic Stent-Graft

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)

Smartphone Ophthalmoscope of Lens Vascularity to Estimate Gestational Age

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Systems of Support Study for Childhood Depression

TR(ACE) Assay Clinical Specimen Study